P-L Etienne - Centre Cario | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 24 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial

T Conroy, F Castan,P-L Etienne, E Rio, N Mesgouez-Nebout, L Evesque, V Vendrely, X Artignan, O Bouché, D Gargot, V Boige, N Bonichon-Lamichhane,

Annals of oncology : official journal of the European Society for Medical Oncology (2024)

引用0浏览0WOS引用

1617P PRODIGE 29-UCGI 26 (NEOPAN): Quality of life results of a phase III randomised trial comparing chemotherapy with folfirinox (FFX) or gemcitabine (gem) in locally advanced pancreatic carcinoma (LAPC)

M.P. Ducreux, R. Desgrippes, Y. Rinaldi,F. Di Fiore, R. Guimbaud, L. Evesque,J-B. Bachet, P. Vanelslander, T. Lecomte, O. Capitain, A. Parzy, M. Bolliet,

Annals of Oncology (2023): S894-S895

引用0浏览0引用

First results of the french prospective cohort of colorectal cancers with microsatellite instability (COLOMIN2)

D. Tougeron, V. Hautefeuille, A. Zaanan,K. Le Malicot, V. Moulin, R. Cohen, T. Lecomte, A. Aleba, J. Viaud, Y. H. Lam,P. L. Etienne, L. Mosser,

ANNALS OF ONCOLOGY (2023): S448-S448

引用0浏览0引用

PRODIGE 29-UCGI 26 (NEOPAN): Quality of life results of a phase III randomised trial comparing chemotherapy with folfirinox (FFX) or gemcitabine (gem) in locally advanced pancreatic carcinoma (LAPC)

M. P. Ducreux, R. Desgrippes, Y. Rinaldi, F. Di Fiore, R. Guimbaud, L. Evesque,J-B. Bachet, P. Vanelslander, T. Lecomte, O. Capitain, A. Parzy, M. Bolliet,

ANNALS OF ONCOLOGY (2023): S894-S895

引用0浏览0引用

390P Impact of age on treatment strategies in RAS/BRAF wild-type metastatic colorectal cancer (mCRC): A prespecified subgroup analysis of the GERCOR-PRODIGE STRATEGIC-1 phase III study

E. Carola,B. Chibaudel, R. Boulahssass, L.M. Dourthe, T. André,J. Henriques, V. Bourgeois,P-L. Etienne,J. Desrame,O. Dupuis, N. Baba-Hamed, D. Auby,

Annals of Oncology（2022）

引用0浏览0引用

Impact of age on treatment strategies in RAS/BRAF wildtype metastatic colorectal cancer (mCRC): A prespecified subgroup analysis of the GERCOR-PRODIGE STRATEGIC-1 phase III study

E. Carola,B. Chibaudel, R. Boulahssass, L. M. Dourthe, T. Andre, J. Henriques, V. Bourgeois,P-L. Etienne,J. Desrame,O. Dupuis, N. Baba-Hamed, D. Auby,

ANNALS OF ONCOLOGYno. 7 (2022): S715-S716

引用0浏览0引用

PRODIGE 29-UCGI 26(NEOPAN): A phase III randomised trial comparing chemotherapy with folfirinox or gemcitabine in locally advanced pancreatic carcinoma (LAPC)

M. P. Ducreux, R. Desgrippes, Y. Rinaldi,F. Di Fiore, R. Guimbaud, P. Follana,J-B. Bachet, P. Vanelslander, T. Lecomte, O. Capitain, A. Parzy, M. Bolliet,

ANNALS OF ONCOLOGY（2022）

引用4浏览0引用

394P Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon adenocarcinoma from PRODIGE 34-FFCD 1402-ADAGE randomized phase III trial

Thomas Aparicio, O. Bouche,P.L. Etienne,Emilie Barbier,L. Mineur, R. Desgrippes, F. Hocine, J.J. Martin, V. Lebrun-Ly, J. Cretin,Jérôme Desramé, Y. Rinaldi,

ANNALS OF ONCOLOGY（2021）

引用1浏览0引用

Apport de la radiomique sur IRM pour prédire la réponse à 2 ans après chimioradiothérapie des cancers du canal anal localement évolués

N. Giraud,T. Aparicio, P. Ronchin, L.-A. Bazire,K. Le Malicot,C. Lemanski,X. Mirabel,P.-L. Étienne, A. Lièvre, W. Cacheux, A. Darut-Jouve,C. de la Fouchardière,

Cancer Radiotherapie（2020）

引用0浏览0引用

LBA21 Neoadjuvant mFOLFIRINOX and preoperative chemoradiation (CRT) versus preoperative CRT in patients with T3-4 rectal cancer: Surgical and quality of life results of PRODIGE 23 phase III trial

C. Borg, E. Rullier,F. Marchal,P-L. Etienne,E. Rio,E. Francois,N. Mesgouez-Nebout,V. Vendrely, X. Artignan, O. Bouche,D. Gargot, V. Boige,

Annals of Oncology（2020）

引用2浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn